Psimaras D, Delattre J-Y
Service de neurologie Mazarin, hôpital de la Salpêtrière, 47, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
Cancer Radiother. 2008 Nov;12(6-7):695-700. doi: 10.1016/j.canrad.2008.09.006. Epub 2008 Sep 30.
The goal of this review is to briefly present the main recent advances of research in malignant gliomas and to consider future developments, in a clinical perspective. The main challenges appear to be the following: (1) To better understand the etiology of gliomas and to differentiate the respective roles of environmental and genetic factors. (2) To improve the diagnostic and follow up tools, not only through refined neuroimaging techniques but also by discovering serum biomarkers. (3) To build a reliable molecular classification of gliomas that may be used for diagnostic and therapeutic purposes. (4) To develop a "molecular-based" clinical research. Neuro-Oncology has now reached a new therapeutic era and many methodological and medico-economic questions need to be solved.
本综述的目的是从临床角度简要介绍恶性胶质瘤研究的主要最新进展,并探讨未来的发展方向。主要挑战似乎如下:(1)更好地理解胶质瘤的病因,区分环境因素和遗传因素各自的作用。(2)不仅通过改进神经影像学技术,还通过发现血清生物标志物来改善诊断和随访工具。(3)建立一种可靠的胶质瘤分子分类,可用于诊断和治疗目的。(4)开展“基于分子的”临床研究。神经肿瘤学现已进入一个新的治疗时代,许多方法学和医学经济学问题有待解决。